These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10869716)

  • 1. Recombinant P2Y receptors: the UCL experience.
    King BF; Townsend-Nicholson A
    J Auton Nerv Syst; 2000 Jul; 81(1-3):164-70. PubMed ID: 10869716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of a recombinant P2Y purinoceptor.
    Simon J; Webb TE; King BF; Burnstock G; Barnard EA
    Eur J Pharmacol; 1995 Nov; 291(3):281-9. PubMed ID: 8719412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2X4: an ATP-activated ionotropic receptor cloned from rat brain.
    Soto F; Garcia-Guzman M; Gomez-Hernandez JM; Hollmann M; Karschin C; Stühmer W
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3684-8. PubMed ID: 8622997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P2 purinoceptors in rat cortical astrocytes: expression, calcium-imaging and signalling studies.
    King BF; Neary JT; Zhu Q; Wang S; Norenberg MD; Burnstock G
    Neuroscience; 1996 Oct; 74(4):1187-96. PubMed ID: 8895885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P2Y and P2X purinoceptor mediated Ca2+ signalling in glial cell pathology in the central nervous system.
    James G; Butt AM
    Eur J Pharmacol; 2002 Jul; 447(2-3):247-60. PubMed ID: 12151016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of purine and pyrimidine nucleotides on intracellular Ca2+ in human eosinophils: activation of purinergic P2Y receptors.
    Mohanty JG; Raible DG; McDermott LJ; Pelleg A; Schulman ES
    J Allergy Clin Immunol; 2001 May; 107(5):849-55. PubMed ID: 11344352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal P2X receptors: localisation and functional properties.
    Nörenberg W; Illes P
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Nov; 362(4-5):324-39. PubMed ID: 11111827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The P2Y purinergic receptor expressed by enteric neurones in guinea-pig intestine.
    Gao N; Hu HZ; Zhu MX; Fang X; Liu S; Gao C; Wood JD
    Neurogastroenterol Motil; 2006 Apr; 18(4):316-23. PubMed ID: 16553587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional evidence that ATP or a related purine is an inhibitory NANC neurotransmitter in the mouse jejunum: study on the identity of P2X and P2Y purinoceptors involved.
    De Man JG; De Winter BY; Seerden TC; De Schepper HU; Herman AG; Pelckmans PA
    Br J Pharmacol; 2003 Nov; 140(6):1108-16. PubMed ID: 14530212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P2Y receptors: focus on structural, pharmacological and functional aspects in the brain.
    Fischer W; Krügel U
    Curr Med Chem; 2007; 14(23):2429-55. PubMed ID: 17979698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular physiology of P2 receptors in the central nervous system.
    Illes P; Alexandre Ribeiro J
    Eur J Pharmacol; 2004 Jan; 483(1):5-17. PubMed ID: 14709321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of P2 Purinergic Receptors in Mesenchymal Stem Cells and Their Roles in Extracellular Nucleotide Regulation of Cell Functions.
    Jiang LH; Hao Y; Mousawi F; Peng H; Yang X
    J Cell Physiol; 2017 Feb; 232(2):287-297. PubMed ID: 27403750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ionotropic ATP receptors in neuronal-glial communication.
    Lalo U; Verkhratsky A; Pankratov Y
    Semin Cell Dev Biol; 2011 Apr; 22(2):220-8. PubMed ID: 21320623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleotides as extracellular signalling molecules.
    Chen ZP; Levy A; Lightman SL
    J Neuroendocrinol; 1995 Feb; 7(2):83-96. PubMed ID: 7767329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular ATP and neurodegeneration.
    Volonté C; Amadio S; Cavaliere F; D'Ambrosi N; Vacca F; Bernardi G
    Curr Drug Targets CNS Neurol Disord; 2003 Dec; 2(6):403-12. PubMed ID: 14683468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purinergic signalling: pathophysiology and therapeutic potential.
    Burnstock G
    Keio J Med; 2013; 62(3):63-73. PubMed ID: 24067872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of P2 receptors in the growth and survival of neurons in the CNS.
    Franke H; Illes P
    Pharmacol Ther; 2006 Mar; 109(3):297-324. PubMed ID: 16102837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P2X2 and P2Y1 immunofluorescence in rat neostriatal medium-spiny projection neurones and cholinergic interneurones is not linked to respective purinergic receptor function.
    Scheibler P; Pesic M; Franke H; Reinhardt R; Wirkner K; Illes P; Nörenberg W
    Br J Pharmacol; 2004 Sep; 143(1):119-31. PubMed ID: 15345659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation by 2,2'-pyridylisatogen tosylate of ATP-responses at a recombinant P2Y1 purinoceptor.
    King BF; Dacquet C; Ziganshin AU; Weetman DF; Burnstock G; Vanhoutte PM; Spedding M
    Br J Pharmacol; 1996 Mar; 117(6):1111-8. PubMed ID: 8882604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of extracellular ATP and P2 receptors in nervous system diseases.
    Tu J; Wang LP
    Neurosci Bull; 2009 Feb; 25(1):27-32. PubMed ID: 19190686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.